These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2153337)

  • 21. Non-ulcer dyspepsia and Campylobacter pylori gastritis: to treat or not to treat?
    Talley NJ
    Med J Aust; 1987 Nov; 147(9):471-2. PubMed ID: 3670207
    [No Abstract]   [Full Text] [Related]  

  • 22. [Campylobacter pylori and treatment of duodenal ulcer].
    Zelenková J; Toman R; Bielaszewská M; Hanika J; Zeman V
    Vnitr Lek; 1990 Jun; 36(6):573-9. PubMed ID: 2219764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacteriological and pharmacological basis for the treatment of Campylobacter pylori infection.
    McNulty CA
    Gastroenterol Clin Biol; 1989; 13(1 Pt 1):96B-100B. PubMed ID: 2663605
    [No Abstract]   [Full Text] [Related]  

  • 24. Campylobacter pylori: its role in gastritis and peptic ulcer disease.
    Hornick RB
    Curr Clin Top Infect Dis; 1989; 10():157-73. PubMed ID: 2679692
    [No Abstract]   [Full Text] [Related]  

  • 25. Campylobacter pylori, hypertrophic erosive gastritis and hypoalbuminemia healed by cephalexin therapy.
    Salmeron M; Desplaces N; Lavergne A; Houdart R
    Gastroenterol Clin Biol; 1989 Jan; 13(1):109-10. PubMed ID: 2925040
    [No Abstract]   [Full Text] [Related]  

  • 26. The role of antibiotics in Campylobacter pylori associated peptic ulcer disease.
    Bayerdörffer E; Ottenjann R
    Scand J Gastroenterol Suppl; 1988; 142():93-100. PubMed ID: 3047854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erythromycin-resistant Campylobacter jejuni.
    Karmali MA; Bannatyne RM; Leers W; Biers K
    Can Med Assoc J; 1980 Aug; 123(4):263, 266. PubMed ID: 7260767
    [No Abstract]   [Full Text] [Related]  

  • 28. [Campylobacter pylori--its role in diseases of the upper digestive tract. The present and future].
    Zamorska I; Jabłońska-Kaszewska I
    Wiad Lek; 1990 Jul; 43(13):672-8. PubMed ID: 2256330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Dose-effect studies with bismuth salts for the elimination of Campylobacter pylori].
    Menge H; Hofmann J; Gregor M
    Z Gastroenterol; 1987 Sep; 25 Suppl 4():44-6. PubMed ID: 3318192
    [No Abstract]   [Full Text] [Related]  

  • 30. [Morphologic change in Campylobacter pylori associated gastritis in and following successful antibacterial therapy].
    Rühl GH; Börsch G
    Pathologe; 1989 Jan; 10(1):64-5. PubMed ID: 2922381
    [No Abstract]   [Full Text] [Related]  

  • 31. [Bismuth aluminate in gastroenterology. Therapeutic effects in chronic erosive Campylobacter pylori-associated gastritis].
    Stanescu A; Malfertheiner P; Mayer D; Baczako K; Ditschuneit H
    Fortschr Med; 1989 Oct; 107(29):623-6. PubMed ID: 2680842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metronidazole-resistant Helicobacter pylori.
    Becx MC; Janssen AJ; Clasener HA; de Koning RW
    Lancet; 1990 Mar; 335(8688):539-40. PubMed ID: 1968548
    [No Abstract]   [Full Text] [Related]  

  • 33. Traveler's diarrhea in Thailand: randomized, double-blind trial comparing single-dose and 3-day azithromycin-based regimens with a 3-day levofloxacin regimen.
    Tribble DR; Sanders JW; Pang LW; Mason C; Pitarangsi C; Baqar S; Armstrong A; Hshieh P; Fox A; Maley EA; Lebron C; Faix DJ; Lawler JV; Nayak G; Lewis M; Bodhidatta L; Scott DA
    Clin Infect Dis; 2007 Feb; 44(3):338-46. PubMed ID: 17205438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Campylobacter (Helicobacter) pylori-induced cost effectiveness-risk considerations].
    Rösch W
    Leber Magen Darm; 1990 Jan; 20(1):45-6. PubMed ID: 2107370
    [No Abstract]   [Full Text] [Related]  

  • 35. Campylobacter pylori and antral gastritis in children.
    De Giacomo C; Maggiore G; Fiocca R
    Am J Gastroenterol; 1988 Feb; 83(2):202-3. PubMed ID: 3341347
    [No Abstract]   [Full Text] [Related]  

  • 36. Campylobacter pylori: a new pathogen.
    Czinn SJ; Speck WT
    Adv Pediatr Infect Dis; 1990; 5():221-37. PubMed ID: 2183821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of Campylobacter pylori does not alter gastric acid secretion.
    Montbriand JR; Appelman HD; Cotner EK; Nostrant TT; Elta GH
    Am J Gastroenterol; 1989 Dec; 84(12):1513-6. PubMed ID: 2596452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Campylobacter pyloridis--a cause of gastritis/ulcer?].
    Gustavsson S
    Lakartidningen; 1986 Aug; 83(35):2822-4. PubMed ID: 3747663
    [No Abstract]   [Full Text] [Related]  

  • 39. Erythromycin-resistant campylobacters.
    Brunton WA; Wilson AM; Macrae RM
    Lancet; 1978 Dec 23-30; 2(8104-5):1385. PubMed ID: 82888
    [No Abstract]   [Full Text] [Related]  

  • 40. Helicobacter pylori and bismuth subnitrate.
    Sodeman WA
    Am J Gastroenterol; 1990 Sep; 85(9):1200-1. PubMed ID: 2389738
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.